title: Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method.
abstract: A novel method to prepare cyclosporin A encapsulated liposomes was introduced using supercritical fluid of carbon dioxide (SCF-CO(2)) as an antisolvent. To investigate the strength of the newly developed SCF-CO(2) method compared with the modified conventional Bangham method, particle size, zeta potential, and polydispersity index (PDI) of both liposomal formulations were characterized and compared. In addition, entrapment efficiency (EE) and drug loading (DL) characteristics were analyzed by reversed-phase high-performance liquid chromatography. Significantly larger particle size and PDI were revealed from the conventional method, while EE (%) and DL (%) did not exhibit any significant differences. The SCF-CO(2) liposomes were found to be relatively smaller, multilamellar, and spherical with a smoother surface as determined by transmission electron microscopy. SCF-CO(2) liposomes showed no significant differences in their particle size and PDI after more than 3 months, whereas conventional liposomes exhibited significant changes in their particle size. The initial yield (%), EE (%), and DL (%) of SCF-CO(2) liposomes and conventional liposomes were 90.98 ± 2.94, 92.20 ± 1.36, 20.99 ± 0.84 and 90.72 ± 2.83, 90.24 ± 1.37, 20.47 ± 0.94, respectively, which changed after 14 weeks to 86.65 ± 0.30, 87.63 ± 0.72, 18.98 ± 0.22 and 75.04 ± 8.80, 84.59 ± 5.13, 15.94 ± 2.80, respectively. Therefore, the newly developed SCF-CO(2) method could be a better alternative compared with the conventional method and may provide a promising approach for large-scale production of liposomes.
authors: Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Yeonsu-gu, Incheon, Republic of Korea.
authors: Pankaj Ranjan
authors: PR
authors: Karn
authors: Wonkyung
authors: W
authors: Cho
authors: Hee-Jun
authors: HJ
authors: Park
authors: Jeong-Sook
authors: JS
authors: Park
authors: Sung-Joo
authors: SJ
authors: Hwang
mesh_terms: D002245:Carbon Dioxide / Q000737:chemistry; D016572:Cyclosporine / Q000138:chemical synthesis / Q000737:chemistry*; D004355:Drug Stability; D005612:Freeze Drying; D008081:Liposomes / Q000138:chemical synthesis / Q000737:chemistry*; D046529:Microscopy, Electron, Transmission; D010316:Particle Size; D013678:Technology, Pharmaceutical
chemical_list: D008081:Liposomes; D002245:Carbon Dioxide; D016572:Cyclosporine
keywords: chemical stability; liposome; physical stability; supercritical carbon dioxide
references: Nanomedicine. 2007 Dec;3(4):273-80
references: 17962084
references: Helv Chim Acta. 1976 Jun 14;59(5):1480-9
references: 931750
references: Int J Pharm. 2007 Jun 29;338(1-2):317-26
references: 17368984
references: Int J Pharm. 2010 Jan 15;384(1-2):140-7
references: 19800955
references: J Liposome Res. 2006;16(3):311-9
references: 16952884
references: J Pharm Sci. 2002 Mar;91(3):856-67
references: 11920770
references: Biomaterials. 2003 Oct;24(23):4283-300
references: 12853260
references: AAPS PharmSciTech. 2008;9(3):798-809
references: 18597175
references: J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2967-73
references: 17048505
references: J Microencapsul. 2012;29(1):21-9
references: 22034954
references: J Control Release. 2011 Feb 28;150(1):70-6
references: 21074586
references: Pharm Acta Helv. 1995 Jul;70(2):95-111
references: 7651973
references: Int J Pharm. 2011 Aug 30;415(1-2):267-72
references: 21645598
references: J Control Release. 2010 Mar 19;142(3):299-311
references: 19874861
references: J Drug Deliv. 2011;2011:591325
references: 21490754
references: Ocul Immunol Inflamm. 2010 Oct;18(5):352-61
references: 20735287
references: J Drug Target. 1998;5(6):443-58
references: 9783676
references: J Mol Biol. 1965 Aug;13(1):238-52
references: 5859039
references: Langmuir. 2006 Mar 14;22(6):2543-50
references: 16519453
references: Biotechnol Bioeng. 2001 Jan 20;72(2):194-204
references: 11114657
references: Langmuir. 2005 Jan 18;21(2):530-6
references: 15641820
references: Eur J Pharm Biopharm. 2003 Nov;56(3):307-18
references: 14602172
references: Int J Pharm. 1999 Nov 30;191(2):87-93
references: 10564835
references: Crit Rev Ther Drug Carrier Syst. 2001;18(2):141-72
references: 11325030
references: Colloids Surf B Biointerfaces. 2008 Dec 1;67(2):238-44
references: 18930640
references: Eur J Pharm Biopharm. 2008 Jun;69(2):454-65
references: 18359211
references: J Oleo Sci. 2011;60(5):209-15
references: 21502720
references: Int J Nanomedicine. 2011;6:2997-3009
references: 22162657
references: Drug Dev Ind Pharm. 2007 Mar;33(3):211-20
references: 17454054
references: Eur J Pharm Biopharm. 2012 Jun;81(2):273-80
references: 22369879
references: J Microencapsul. 1991 Oct-Dec;8(4):441-6
references: 1798016
references: Int J Pharm. 2001 Mar 23;216(1-2):17-21
references: 11274802
references: Appl Opt. 2001 Aug 20;40(24):4087-91
references: 18360445
references: Int J Nanomedicine. 2011;6:965-74
references: 21720508
references: Drug Dev Ind Pharm. 2011 Apr;37(4):482-8
references: 20961263
references: Transplantation. 1995 Nov 15;60(9):999-1006
references: 7491708